Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis
Top Cited Papers
- 3 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (5) , 413-423
Abstract
Haemostasis refers to the physiological process aimed at repairing vessel injury and preventing bleeding. It involves four interlinked stages culminating in the formation of a platelet–fibrin haemostatic plug that is eventually dissolved once the vessel heals. In contrast, arterial thrombosis is a pathological condition resulting from atheroma exposure, triggering the formation of a platelet-rich thrombus that may obstruct blood flow, leading to the clinical manifestations of ischaemic cardiovascular disease. The following review will provide a comprehensive overview of the finely regulated endogenous antithrombotic mechanisms responsible for maintaining the haemostatic balance and preventing intravascular thrombosis. Thereafter, it will further detail the different stages and mechanisms governing the intricate interplay between the vessel, platelets, and the coagulation cascade in haemostasis, highlighting the most recent advances in platelet biology and function, to further elucidate the differential traits and players contributing to pathological arterial thrombus growth. The review will also delve into the impact of emerging cardiovascular risk factors on tilting the haemostatic balance towards a pro-thrombotic state, thereby increasing the patient’s vulnerability to thrombotic events. Finally, it will underscore the importance of early screening for subclinical atherosclerosis through advanced imaging technologies capable of quantifying plaque burden and metabolic activity since they may set the stage for an increased thrombotic risk. Implementing proactive interventions to halt atherosclerosis progression or inducing its regression at early stages is crucial for preserving haemostasis and reducing the likelihood of ischaemic atherothrombotic disease.Keywords
Funding Information
- Unión Europea NextGenerationEU/PRTR (M-ERA-NET-3/PCI2023-143431)
- EU Horizon 2020 (MCIN/AEI/10.13039/501100011033)
- Fondo Europeo de Desarrollo Regional
This publication has 145 references indexed in Scilit:
- Seeing is believing: pathway strategies for a personalised non-invasive diagnosis of coronary artery diseaseInternal and Emergency Medicine, 2024
- Does Coronary Plaque Morphology Matter Beyond Plaque Burden?Current Atherosclerosis Reports, 2023
- Lipoprotein(a) and its Significance in Cardiovascular DiseaseJAMA Cardiology, 2022
- Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion InjuryCardiovascular Drugs and Therapy, 2022
- Vitamin D inhibits Tissue Factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway.European Journal of Pharmacology, 2020
- Tissue factor in atherosclerosis and atherothrombosisAtherosclerosis, 2020
- 3D ultrastructural analysis of α‐granule, dense granule, mitochondria, and canalicular system arrangement in resting human plateletsResearch and Practice in Thrombosis and Haemostasis, 2019
- Adenosine and the Cardiovascular SystemAmerican Journal of Cardiovascular Drugs, 2019
- Fibrinolysis and the control of blood coagulationBlood Reviews, 2015
- The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and designAmerican Heart Journal, 2013